.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Covington
US Army
McKesson
Novartis
AstraZeneca
Cerilliant
UBS
Express Scripts
Julphar

Generated: November 21, 2017

DrugPatentWatch Database Preview

Actavis Labs Fl Inc Company Profile

« Back to Dashboard

What is the competitive landscape for ACTAVIS LABS FL INC, and what generic and branded alternatives to ACTAVIS LABS FL INC drugs are available?

ACTAVIS LABS FL INC has sixty-nine approved drugs.

There are two tentative approvals on ACTAVIS LABS FL INC drugs.

Summary for Actavis Labs Fl Inc

US Patents:0
Tradenames:54
Ingredients:52
NDAs:69
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Labs Fl Inc
CIPROFLOXACIN EXTENDED RELEASE
ciprofloxacin; ciprofloxacin hydrochloride
TABLET, EXTENDED RELEASE;ORAL077809-001Nov 30, 2010DISCNNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
TAMOXIFEN CITRATE
tamoxifen citrate
TABLET;ORAL076179-001Feb 20, 2003DISCNNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
LACOSAMIDE
lacosamide
TABLET;ORAL204855-001Apr 28, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
METFORMIN HYDROCHLORIDE
metformin hydrochloride
TABLET, EXTENDED RELEASE;ORAL076869-001Apr 12, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
TAMOXIFEN CITRATE
tamoxifen citrate
TABLET;ORAL070929-001Feb 20, 2003ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
NAPROXEN SODIUM
naproxen sodium
TABLET, EXTENDED RELEASE;ORAL075416-003Aug 11, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
PALIPERIDONE
paliperidone
TABLET, EXTENDED RELEASE;ORAL202645-001Aug 3, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
PALIPERIDONE
paliperidone
TABLET, EXTENDED RELEASE;ORAL202645-004Aug 3, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
benazepril hydrochloride; hydrochlorothiazide
TABLET;ORAL076342-004Feb 11, 2004DISCNNoNo► Subscribe► Subscribe► Subscribe
Actavis Labs Fl Inc
DUTASTERIDE AND TAMSULOSIN HYDROCHLORIDE
dutasteride; tamsulosin hydrochloride
CAPSULE;ORAL202975-001Nov 20, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for ACTAVIS LABS FL INC drugs

Drugname Dosage Strength Tradename Submissiondate
omeprazole
Delayed-release Tablets20 mg
OMEPRAZOLE
6/3/2015

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Deloitte
UBS
Julphar
McKesson
Johnson and Johnson
Merck
Farmers Insurance
Queensland Health
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot